Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Definitive Healthcare (DH) Research & Development (2020 - 2026)

Definitive Healthcare filings provide 6 years of Research & Development readings, the most recent being $10.0 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 10.82% to $10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.8 million, a 4.77% decrease, with the full-year FY2025 number at $34.8 million, down 4.77% from a year prior.
  • Research & Development hit $10.0 million in Q4 2025 for Definitive Healthcare, up from $7.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $11.6 million in Q4 2023 to a low of $3.8 million in Q1 2021.
  • Median Research & Development over the past 5 years was $9.1 million (2022), compared with a mean of $8.4 million.
  • Biggest five-year swings in Research & Development: soared 103.55% in 2022 and later plummeted 32.32% in 2024.
  • Definitive Healthcare's Research & Development stood at $5.7 million in 2021, then soared by 76.22% to $10.1 million in 2022, then grew by 14.22% to $11.6 million in 2023, then decreased by 22.36% to $9.0 million in 2024, then increased by 10.82% to $10.0 million in 2025.
  • The last three reported values for Research & Development were $10.0 million (Q4 2025), $7.6 million (Q3 2025), and $8.0 million (Q2 2025) per Business Quant data.